RBC Capital Reiterates Outperform on Eli Lilly, Maintains $1600 Price Target

Benzinga · 1d ago
RBC Capital analyst Trung Huynh reiterates Eli Lilly (NYSE:LLY) with a Outperform and maintains $1600 price target.